Physician profile
Marcela C Ramirez
NPI 1578724365
$5,305.58
in general payments reported to CMS, 2019-2025
31 companies · $1,056 in 2025
The $1,056 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $621 · 2020: $555 · 2021: $330 · 2022: $579 · 2023: $903 · 2024: $1,262 · 2025: $1,056.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,220.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $1,208.65 | 2020-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Biotissue Holdings INC. | $430.41 | 2023-2025 | |
| Zimmer Biomet Holdings, INC. | $379.49 | 2019-2023 | Advantagerib |
| Medtronic, INC. | $374.45 | 2022-2024 | Mycarelink, Ligasure, Signia |
| Davol INC. | $357.76 | 2022-2025 | Phasix Mesh, Arista |
| Atricure, INC. | $292.70 | 2022-2024 | |
| Acell, INC. | $291.12 | 2019 | |
| Allergan, INC. | $284.04 | 2019-2021 | |
| Polynovo North America LLC | $155.50 | 2025 | Novosorb Btm |
| Kerecis Limited | $151.94 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Takeda Pharmaceuticals U.S.A., INC. | $127.14 | 2025 | Gattex |
| Edwards Lifesciences Corporation | $125.44 | 2021 | |
| Depuy Synthes Sales INC. | $125.00 | 2020 | |
| Teleflex LLC | $124.41 | 2020 | |
| Kci USA, INC. | $120.91 | 2023 | Abthera Advance, Prevena, V.A.C. Veraflo Cleanse Choice |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $119.75 | 2024 | |
| Abbvie INC. | $113.17 | 2023 | |
| Aroa Biosurgery Incorporated | $112.31 | 2024-2025 | |
| Prytime Medical Devices, INC. | $111.94 | 2025 | Er-Reboa Plus |
| Si-Bone, INC. | $54.17 | 2024 | |
| Solventum Corporation | $38.42 | 2024-2025 | Prevena, V.A.C. Veraflo Cleanse Choice, Abthera |
| Kls-Martin L.P. | $30.03 | 2021 | |
| Tei Biosciences INC | $23.99 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $23.67 | 2025 | Eliquis |
| Pfizer INC. | $23.63 | 2025 | |
| Avanos Medical | $21.94 | 2019 | |
| Celularity INC. | $20.00 | 2019 | |
| Access Pro Medical, LLC | $19.83 | 2025 | Matriderm |
| Pacira Pharmaceuticals Incorporated | $15.59 | 2021 | |
| Amniox Medical, INC. | $15.46 | 2019 | |
| Molnlycke Health Care US, LLC | $12.72 | 2024 | Avance, Mepilex Border Post-Op Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcela Ramirez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.